BNGO
Bionano Genomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.20
−3.23%Leverage
- Debt / equity
- 0.21x
- Net debt / equity
- 0.09x
- Debt / assets
- 0.14x
- Debt / EBITDA
- -0.30x
- Net debt / EBITDA
- -0.13x
Liquidity & coverage
- Current ratio
- 2.48x
- Quick ratio
- 1.96x
- Cash ratio
- 0.99x
- Interest coverage
- -151.12x
- EBITDA / interest
- -105.22x
- Working capital
- $14.8M
Cash & dividend
- FCF / debt
- -3.05x
- Cash flow / debt
- -3.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026